Please login to the form below

Not currently logged in
Email:
Password:

Vertex poaches new finance chief from Ironwood Pharmaceuticals

Boston-based biotech company appoints Tom Graney

Vertex Tom GraneyVertex lured Tom Graney away from Ironwood Pharmaceuticals, appointing him as its new senior vice president and chief financial officer.

He will join the Boston-based biotech firm next week, when he will be responsible for the development and execution of Vertex’s financial strategy and operations.

Graney will report to Vertex’s chief operating office Ian Smith, who said: “As Vertex continues its evolution to a leading global biotech, it is critical that we continue to build a strong and experienced leadership team.

“Tom has the ideal blend of financial acumen, leadership skills, and industry experience that will be important as Vertex grows and expands as a global company."

Graney most recently spent three years at Ironwood Pharmaceuticals, overseeing its Finance, Corporate Strategy, Corporate Development, Quality, Supply Chain, IT, Corporate Communications and Investor Relations functions.

Prior to that he served at Johnson & Johnson for 20 years in the US and abroad, rising to worldwide VP of finance and CFO for its Ethicon Surgical Care business.

At Ironwood Pharmaceuticals Graney’s replacement as interim chief financial officer will be Gina Consylman, who currently serves as the Cambridge, Massachusetts firm’s VP of finance and chief accounting officer.

8th September 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics